Add like
Add dislike
Add to saved papers

Optimal slow pathway ablation site for slow-fast atrioventricular nodal reentrant tachycardia with 2:1 atrioventricular conduction.

BACKGROUND: The exact circuit responsible for the atrioventricular (AV) nodal reentrant tachycardia (AVNRT) is still unknown. We evaluated the optimal slow pathway ablation area in patients with and without 2:1 AV conduction during the slow-fast AVNRT.

METHODS: Among 207 consecutive patients with slow-fast AVNRT who underwent slow pathway ablation, 12 (5.8 %) patients who had 2:1 AV conduction during tachycardia (group A) were included. Fifty-nine patients without 2:1 AV conduction during tachycardia or a lower common pathway (group B) were included as a control group. We measured the fluoroscopic vertical distance on the 45° left anterior oblique view between the optimal slow pathway ablation area and His bundle electrogram (HBE) recording site (height AH) and between the coronary sinus ostium and HBE site (height CH). The horizontal distances (width AH, width CH) on the 30° right anterior view were also measured.

RESULTS: The tachycardia cycle length (300 ± 39 vs. 371 ± 71 ms, p = 0.001) and AH interval during tachycardia (259 ± 33 vs. 324 ± 69 ms, p = 0.001) were significantly shorter in group A than in group B. The height AH/height CH was significantly smaller in group A than in group B (0.62 ± 0.15 vs. 0.76 ± 0.27, p = 0.034) whereas height CH was similar between the two groups (22.8 ± 6.4 vs. 23.4 ± 7.5 mm, p = 0.84). The width CA and width CH were similar between the two groups. Slow pathway ablation was successfully achieved in all 71 patients without any complications. The number of applications tended to be greater in group A than in group b; however, the difference did not reach statistical significance (8.8 ± 8.0 vs. 5.2 ± 5.2, p = 0.147).

CONCLUSIONS: The optimal slow pathway ablation area was located at a more superior position in group A than in group b.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app